Iradimed (IRMD) Change in Accured Expenses (2013 - 2026)
Iradimed's (IRMD) quarterly Change in Accured Expenses came in at $993000.0 in Q2 2026, up 5.3% year-over-year from $943000.0 in Q2 2025, and up 186.2% quarter-over-quarter from -$1.2 million in Q1 2026.
Powered by 
Analysis
Iradimed (IRMD) Change in Accured Expenses (2013 - 2026) Analysis & Trends
Iradimed (IRMD) has reported Change in Accured Expenses for 14 consecutive years, with $993000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Change in Accured Expenses rose 5.3% year-over-year to $993000.0 in Q2 2026; TTM through Jun 2026 was -$151000.0, a 149.44% decrease from a year earlier, with the FY2025 full-year figure at -$554000.0, down 155.57% from the prior year.
- Change in Accured Expenses was $993000.0 for Q2 2026 at Iradimed, up from -$1.2 million in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $993000.0 in Q2 2026 and troughed at -$1.5 million in Q1 2025.
- A 5-year average of $21531.4 and a median of $348940.0 in 2022 frame the typical range for Change in Accured Expenses.
- Across the five-year window, Change in Accured Expenses soared 994.01% in 2024 and plunged 274.93% in 2025, its largest moves.
- Over 5 years, Change in Accured Expenses stood at $318353.0 in 2022, then surged by 161.25% to $831699.0 in 2023, then plunged by 41.34% to $487877.0 in 2024, then sank by 274.93% to -$853420.0 in 2025, then surged by 216.36% to $993000.0 in 2026.
- The last three Change in Accured Expenses figures came in at $993000.0 (Q2 2026), -$1.2 million (Q1 2026), and -$853420.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 55.00 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -531.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 298.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 234.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 123.70 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -74.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 112.90 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 4.80 Mn |
| 10 | Iradimed | 1.07 Bn | 1.01 Bn | 15.16 Mn | 993,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 993,000.00 |
| Mar 31, 2026 | -1.15 Mn |
| Dec 31, 2025 | -853,420.00 |
| Sep 30, 2025 | 861,420.00 |
| Jun 30, 2025 | 943,000.00 |
| Mar 31, 2025 | -1.51 Mn |
| Dec 31, 2024 | 487,877.00 |
| Sep 30, 2024 | 379,527.00 |
| Jun 30, 2024 | 760,478.00 |
| Mar 31, 2024 | -630,882.00 |
| Dec 31, 2023 | 831,699.00 |
| Sep 30, 2023 | -42,452.00 |
| Jun 30, 2023 | 716,007.00 |
| Mar 31, 2023 | -1.26 Mn |
| Dec 31, 2022 | 318,353.00 |
| Sep 30, 2022 | 80,605.00 |
| Jun 30, 2022 | 391,692.00 |
| Mar 31, 2022 | -937,085.00 |
| Dec 31, 2021 | 400,574.00 |
| Sep 30, 2021 | 403,912.00 |